Skip to main content

Table 2 Side effects and serious adverse events in patients receiving triple therapy

From: Safety and efficacy of protease inhibitor based combination therapy in a single-center “real-life” cohort of 110 patients with chronic hepatitis C genotype 1 infection

 

Number

BOC

TPR

P-Value

 

(N = 102)

(N = 37)

(N = 65)

 

Grade 3/4 anemia

13 (12.7%)§

4 (10.8%)

9 (13.8%)

0.77

Grade 3/4 neutropenia

25 (24.5%)

12 (32.4%)

13 (20%)

0.23

Grade 3/4 thrombopenia

14 (13.7%)

3 (8.1%)

11 (16.9%)

0.25

Flu-like symptoms

44 (43.1%)

20 (54.1%)

24 (36.9%)

0.10

GI disorders

43 (42.2%)

16 (43.2%)

27 (41.5%)

1

Grade 1/2 rash

35 (34.3%)

11 (29.7%)

24 (36.9%)

0.52

Psychiatric disorder

29 (28.4%)§§

11 (29.7%)

18 (27.7%)

1

Fatigue

27 (26.5%)

15 (40.5%)

12 (18.5%)

0.02

Anorectal dyscomfort

25 (24.5%)

1 (2.7%)

24 (36.9%)§§§

<0.01

Insomnia

23 (22.5%)

7 (18.9%)

16 (24.6%)

0.63

Bronchopulmonal symptoms

20 (19.6%)

9 (24.3%)

11 (16.9%)

0.44

Dysgeusia

10 (9.8%)

9 (24.3%)

1 (1.5%)

<0.01

Immunothyreoiditis

4 (3.9%)

0

4 (6.2%)

0.29

Serious adverse event

Number

Comments/Outcome

Grade 4 anemia

2

Both patients received blood transfusions

Grade 4 neutropenia

3

1 patient with neutropenic sepsis; all 3 recovered after dose reduction of peginterferon

Grade 4 thrombopenia

6

1 patient received a platelet concentrate

Grade 3 rash

4

TPR was discontinued early in 1 patient

DRESS/SJS

None

-

Neurological symptoms

2

Radial nerve paresis (recovery after physiotherapy) and urine incontinency (ongoing)

Localized infections

3

All fully recovered (balanitis, epididymitis, perspiratory gland abscess)

Sepsis

4

2 patients recovered; 2 patients died

Hepatic decompensation

2

Both recovered, but 1 patient died 6 weeks after discontinuation of treatment

Decompensation of autoimmune disorder

1

First manifestation of autoimmune diabetes mellitus.

Ileus

2

Fully recovered after surgical intervention (1x) or conservative treatment (1x)

Cardiac complications

1

Unstable angina pectoris, full recovery after PTCA with stent implantation

  1. 30 SAE occured in 22 individuals. [BOC = boceprevir; TPR = telaprevir; N = number; GI = gastrointestinal; DRESS = drug induced rash and eosinophilia with systemic symptoms; SJS = Stevens Johnson syndrome; PTCA = percutaneous coronary angiography; § = 5 patients received transfusion; §§ = 9 patients with history of psychiatric illness; §§§ = hemorrhagic proctitis in 5 patients].